GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InfuSystems Holdings Inc (FRA:1TZ) » Definitions » Cyclically Adjusted PS Ratio

InfuSystems Holdings (FRA:1TZ) Cyclically Adjusted PS Ratio : 1.35 (As of Jun. 23, 2024)


View and export this data going back to 2021. Start your Free Trial

What is InfuSystems Holdings Cyclically Adjusted PS Ratio?

As of today (2024-06-23), InfuSystems Holdings's current share price is €5.95. InfuSystems Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €4.42. InfuSystems Holdings's Cyclically Adjusted PS Ratio for today is 1.35.

The historical rank and industry rank for InfuSystems Holdings's Cyclically Adjusted PS Ratio or its related term are showing as below:

FRA:1TZ' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.46   Med: 1.81   Max: 6.41
Current: 1.39

During the past years, InfuSystems Holdings's highest Cyclically Adjusted PS Ratio was 6.41. The lowest was 0.46. And the median was 1.81.

FRA:1TZ's Cyclically Adjusted PS Ratio is ranked better than
64.09% of 479 companies
in the Medical Devices & Instruments industry
Industry Median: 2.12 vs FRA:1TZ: 1.39

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

InfuSystems Holdings's adjusted revenue per share data for the three months ended in Mar. 2024 was €1.387. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is €4.42 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


InfuSystems Holdings Cyclically Adjusted PS Ratio Historical Data

The historical data trend for InfuSystems Holdings's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InfuSystems Holdings Cyclically Adjusted PS Ratio Chart

InfuSystems Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.66 5.47 4.43 2.04 2.29

InfuSystems Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.77 2.15 2.11 2.29 1.81

Competitive Comparison of InfuSystems Holdings's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, InfuSystems Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InfuSystems Holdings's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where InfuSystems Holdings's Cyclically Adjusted PS Ratio falls into.



InfuSystems Holdings Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

InfuSystems Holdings's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=5.95/4.42
=1.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InfuSystems Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, InfuSystems Holdings's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.387/131.7762*131.7762
=1.387

Current CPI (Mar. 2024) = 131.7762.

InfuSystems Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.538 100.560 0.705
201409 0.573 100.428 0.752
201412 0.571 99.070 0.760
201503 0.686 99.621 0.907
201506 0.661 100.684 0.865
201509 0.714 100.392 0.937
201512 0.746 99.792 0.985
201603 0.713 100.470 0.935
201606 0.698 101.688 0.905
201609 0.667 101.861 0.863
201612 0.706 101.863 0.913
201703 0.728 102.862 0.933
201706 0.663 103.349 0.845
201709 0.648 104.136 0.820
201712 0.701 104.011 0.888
201803 0.585 105.290 0.732
201806 0.619 106.317 0.767
201809 0.691 106.507 0.855
201812 0.790 105.998 0.982
201903 0.822 107.251 1.010
201906 0.848 108.070 1.034
201909 0.944 108.329 1.148
201912 0.894 108.420 1.087
202003 0.979 108.902 1.185
202006 1.067 108.767 1.293
202009 0.985 109.815 1.182
202012 0.925 109.897 1.109
202103 0.937 111.754 1.105
202106 0.934 114.631 1.074
202109 1.097 115.734 1.249
202112 1.057 117.630 1.184
202203 1.179 121.301 1.281
202206 1.243 125.017 1.310
202209 1.284 125.227 1.351
202212 1.119 125.222 1.178
202303 1.360 127.348 1.407
202306 1.356 128.729 1.388
202309 1.377 129.860 1.397
202312 1.340 129.419 1.364
202403 1.387 131.776 1.387

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


InfuSystems Holdings  (FRA:1TZ) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


InfuSystems Holdings Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of InfuSystems Holdings's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


InfuSystems Holdings (FRA:1TZ) Business Description

Traded in Other Exchanges
Address
3851 West Hamlin Road, Rochester Hills, MI, USA, 48309
InfuSystems Holdings Inc is a United States based healthcare service provider. It offers Infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care from the locations in the United States and Canada. The company provides products and services to hospitals, oncology practices and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The segments of the company are Integrated Therapy Services (ITS) and Durable Medical Equipment (DME) services, of which key revenue is derived from the ITS segment.

InfuSystems Holdings (FRA:1TZ) Headlines

No Headlines